[Secondary bronchopulmonary aspergillosis. (Anatomo-pathological and pathogenetic contributon)].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001228:Aspergillosis / Q000209:etiology*; D001982:Bronchial Diseases / Q000209:etiology*; D002177:Candidiasis / Q000209:etiology*; D050723:Fractures, Bone / Q000150:complications*; D006689:Hodgkin Disease / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007938:Leukemia / Q000150:complications*; D008172:Lung Diseases, Fungal / Q000209:etiology*; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010384:Pelvic Bones / Q000293:injuries*; D014376:Tuberculosis / Q000150:complications*; D014552:Urinary Tract Infections / Q000150:complications*
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Aspergillosi broncopolmonare secondaria. (Contributo anatomo-patologico e patogenetico)